Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 106

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 106
---
                             
 Net Income ( Loss) for the quarter          |     | Shares             
 Series A Preferred 
 Shares             |     |    409,551 
          - 
          - |     | Amount 
 Amount |    40 
     - 
     - 
     - |     | Shares              
 Series AA Preferred 
 Shares              | 34 |     | Amount 
 Amount | - 
 - 
 - |     | Shares              
 Series NC Preferred 
 Shares              | 15,007 
      - |     | Amount 
 Amount | 2 
 - 
 - |     | Shares 
 Common 
 Shares |  3,506,366 
    244,199 |     | Amount 
 Amount |   352 
    24 |     | Shares             
 Series M Preferred 
 Shares             | 29,338 |     | Amount 
 Amount | 3 
 - 
 - |     | Capital    
 Additional 
 Paid- in   
 Capital    | 14,644,467 
    212,272 |   |     | Income        
 Accumulated   
 Other         
 Comprehensive 
 Income        | -        
 (204,847 | ) |     | Deficit     
 Accumulated 
 Deficit     | (19,748,863 
 (144,933    | ) 
 ) |     | Total 
 Total | (5,103,999 
    212,296 
   (204,847 
   (144,933 | ) 
 ) 
 ) |
|:--------------------------------------------|:----|:-------------------|:----|-----------:|:----|:-------|------:|:----|:--------------------|---:|:----|:-------|:--|:----|:--------------------|-------:|:----|:-------|--:|:----|:-------|-----------:|:----|:-------|------:|:----|:-------------------|-------:|:----|:-------|--:|:----|:-----------|-----------:|:--|:----|:--------------|:---------|:--|:----|:------------|:------------|:--|:----|:------|-----------:|:--|
| Balance December 31, 2023                   |     |                    |     |    409,551 |     | $      |    40 |     |                     | 34 |     |        | - |     |                     | 15,007 |     | $      | 2 |     |        |  3,750